Skip to main content
All lobbying clients

RIO BIOPHARMACEUTICALS, INC.

Lobbying client · New Jersey · filed 2025 to 2026

Pharmaceutical company

$700,000 Reported spend
6 Filings counted
1 Firms hired
0 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (67244), not by name.

 Firms hired 1
 Reported by year 2 years
  • 2026 $300,000 2 filings
  • 2025 $400,000 4 filings
 Issues lobbied 1

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 7
  • Health & Human Services, Dept of (HHS) 5
  • Commerce, Dept of (DOC) 2
  • Executive Office of the President (EOP) 2
  • HOUSE OF REPRESENTATIVES 2
  • SENATE 2
  • White House Office 2
  • Food & Drug Administration (FDA) 1
 Foreign entities disclosed 3
  • GLOBE PHARMA S.A.R.L. Luxembourg named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $0
  • SALTMONT FUNDO DE INVESTIMENTO EM PARTICIPAOES MULTIESTRATEGIA INVESTIMENTO NO EXTERIOR (HOLDS 75% OF GLOBE PHARMA S.A.R.L) Brazil named on 1 filing · highest disclosed ownership 75% · largest disclosed contribution $0
  • YANKEE-F FUNDO DE INVESTIMENTO MULTIMERCADO CREDITO PRIVADO INVESTIMENTO NO EXTERIOR (HOLDS 88% OF SALTMONT FIP) Brazil named on 1 filing · highest disclosed ownership 66% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem